Literature DB >> 1549350

Alternate mechanisms of ras activation are complementary and favor and formation of ras-GTP.

G Patel1, M J MacDonald, R Khosravi-Far, M M Hisaka, C J Der.   

Abstract

The mechanisms of ras activation by mutations in residue 61 and in the NKXD guanine nucleotide-binding consensus sequence (ras residues 116-119) have been evaluated. Weakly transforming mutations that either reduce intrinsic and GTPase-activating protein (GAP)-stimulated GTPase activities (61P) or enhance guanine nucleotide exchange rates (116H, 119E) were combined into the same H-ras proteins. The resulting double-mutant proteins exhibited significantly stronger transforming forming activities than are observed with each individual mutation, suggesting that the consequences of these two different mechanisms of activation favor maintenance of ras in the active form, which is GTP bound. In vivo nucleotide association analysis demonstrated a direct relationship between ras-GTP formation and transforming activity. Although both 61P and 61L mutations result in reduced intrinsic GTPase activity and loss of GAP stimulation in vitro, only H-ras(61L) exhibits strong transforming activity. While H-ras(61L) is found predominantly in the GTP-bound form, H-ras(61P) is predominantly complexed with GDP in vivo. Thus, in vitro GAP stimulation of GTPase activity does not directly correlate with transforming potential, suggesting that other ras-specific regulatory components may also be important in regulating the cycling of ras between CDP- and GTP-bound states.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1549350

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  8 in total

1.  Regulated and constitutive activity by CDC25Mm (GRF), a Ras-specific exchange factor.

Authors:  H Cen; A G Papageorge; W C Vass; K E Zhang; D R Lowy
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

2.  Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein.

Authors:  A D Cox; M M Hisaka; J E Buss; C J Der
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

3.  Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras.

Authors:  R Khosravi-Far; M Chrzanowska-Wodnicka; P A Solski; A Eva; K Burridge; C J Der
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

Review 4.  Human RAS superfamily proteins and related GTPases.

Authors:  John Colicelli
Journal:  Sci STKE       Date:  2004-09-07

5.  A Novel System for Functional Determination of Variants of Uncertain Significance using Deep Convolutional Neural Networks.

Authors:  Lior Zimmerman; Ori Zelichov; Arie Aizenmann; Zohar Barbash; Michael Vidne; Gabi Tarcic
Journal:  Sci Rep       Date:  2020-03-06       Impact factor: 4.379

6.  Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism.

Authors:  Piro Lito; Martha Solomon; Lian-Sheng Li; Rasmus Hansen; Neal Rosen
Journal:  Science       Date:  2016-01-14       Impact factor: 47.728

7.  Human Miro Proteins Act as NTP Hydrolases through a Novel, Non-Canonical Catalytic Mechanism.

Authors:  Daniel T Peters; Laura Kay; Jeyanthy Eswaran; Jeremy H Lakey; Meera Soundararajan
Journal:  Int J Mol Sci       Date:  2018-12-02       Impact factor: 5.923

8.  GTP-binding mutants of rab1 and rab2 are potent inhibitors of vesicular transport from the endoplasmic reticulum to the Golgi complex.

Authors:  E J Tisdale; J R Bourne; R Khosravi-Far; C J Der; W E Balch
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.